产前保健扩展与拉美裔急诊医疗补助受益者妊娠期糖尿病抗糖尿病药物使用的关系
这项队列研究利用关联的医疗补助索赔和出生证明数据,纳入2010年10月1日至2019年12月31日期间4869例拉美裔患者的活产,采用双重差分设计比较俄勒冈州2013年推出产前保健服务与未覆盖产前及产后保健的南卡罗来纳州。结果显示,政策改变后妊娠期糖尿病患者接受抗糖尿病药物的比例从0.3%(2/617)升至28.8%(295/1023),调整模型增加27.9个百分点(95%CI 24.5-31.2);胰岛素使用增加10.4个百分点(95%CI 5.3-15.5);产后避孕使用增加21.2个百分点(95%CI 14.9-27.5),其中产后绝育增加16.1个百分点(95%CI 10.4-21.8)。妊娠期高血压、剖宫产或新生儿健康未见显著关联。作者认为,扩展急诊医疗补助福利纳入产前保健与妊娠期抗糖尿病药物及产后避孕使用增加相关。
要点
- 俄勒冈州政策改变后,妊娠期糖尿病患者接受抗糖尿病药物(口服药或胰岛素)的比例从0.3%(2/617)升至28.8%(295/1023),调整模型增加27.9个百分点(95%CI 24.5-31.2)。
- 政策改变与妊娠期糖尿病患者妊娠期胰岛素使用增加10.4个百分点相关(95%CI 5.3-15.5)。
- 政策改变与产后避孕使用增加21.2个百分点相关(95%CI 14.9-27.5),其中产后绝育增加16.1个百分点(95%CI 10.4-21.8)。
- 妊娠期高血压、剖宫产和新生儿健康(大于胎龄儿、新生儿重症监护病房入住、早产复合结局)未见显著关联。
- 研究样本为急诊医疗补助参保的拉美裔活产患者4869例,平均(标准差)年龄32.7(5.5)岁(范围12-44岁),主要年龄25-34岁(1499/2907,51.6%),多产(2626/2907,90.3%),居住城市(2299/2907,79.1%)。
适用人群与场景
- 2010年10月1日至2019年12月31日期间,俄勒冈州和南卡罗来纳州急诊医疗补助参保的拉美裔活产患者,共4869例。
- 样本平均(标准差)年龄32.7(5.5)岁(范围12-44岁),主要年龄25-34岁(1499/2907,51.6%),多产(2626/2907,90.3%),居住城市(2299/2907,79.1%)。
研究设计与关键结果
- 研究设计为队列研究,采用双重差分设计,利用关联的医疗补助索赔和出生证明数据,比较俄勒冈州2013年推出的产前保健服务与未覆盖产前及产后保健的南卡罗来纳州。
- 主要结局为接受抗糖尿病药物:政策改变前,妊娠期糖尿病患者中仅0.3%(2/617)接受任何药物(口服药或胰岛素)控制血糖;政策改变后,28.8%(295/1023)接受药物,调整模型增加27.9个百分点(95%CI 24.5-31.2)。
- 次要结局:政策改变与妊娠期胰岛素使用增加10.4个百分点相关(95%CI 5.3-15.5);产后避孕使用增加21.2个百分点(95%CI 14.9-27.5),其中产后绝育增加16.1个百分点(95%CI 10.4-21.8)。
- 妊娠期高血压、剖宫产和新生儿健康(大于胎龄儿、新生儿重症监护病房入住、早产复合结局)未见显著关联。
证据类型、等级与局限
- 证据类型:回顾性队列研究,采用双重差分设计。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,扩展急诊医疗补助福利纳入产前保健与妊娠期抗糖尿病药物及产后避孕使用增加相关。
- 研究未观察到与妊娠期高血压、剖宫产或新生儿健康的显著关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Access to necessary prenatal care is not guaranteed through Medicaid for some people with low income based on their immigration status. Although states have the option to extend emergency Medicaid coverage for prenatal care, many states have not expanded coverage.
OBJECTIVE: To evaluate whether the receipt of prenatal care services through the extension of emergency Medicaid coverage is associated with an increase in antidiabetic medication use among Latina patients with gestational diabetes.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used linked Medicaid claims and birth certificate data on live births to 4869 Latina patients from October 1, 2010, to December 31, 2019, with a difference-in-differences design to compare the rollout of prenatal care and services in Oregon in 2013 with a comparison state, South Carolina, that did not cover prenatal or postpartum care.
EXPOSURE: Medicaid coverage of prenatal care.
MAIN OUTCOMES AND MEASURES: The main outcome was the receipt of antidiabetic agents. Secondary outcomes included hypertensive disorders, cesarean delivery, postpartum contraception, and a newborn morbidity composite outcome (large size for gestational age, neonatal intensive care unit admission, and preterm birth).
RESULTS: The study sample included live births to 4869 Latina patients (mean [SD] age, 32.7 [5.5] years [range, 12-44 years]) enrolled in emergency Medicaid who were mainly aged 25 to 34 years (1499 of 2907 [51.6%]), multiparous (2626 of 2907 [90.3%]), and living in urban areas (2299 of 2907 [79.1%]). After Oregon's policy change to offer prenatal coverage to individuals receiving emergency Medicaid, there was a large and significant increase in the receipt of antidiabetic agents among all people with diabetes during pregnancy (gestational diabetes). Prior to the policy, only 0.3% of all Latina emergency Medicaid recipients with gestational diabetes (2 of 617) received any medication (oral agents or insulin) to manage their blood glucose level. After the policy change, 28.8% of all patients with gestational diabetes (295 of 1023) received medication to manage their blood glucose level, translating to a 27.9-percentage-point increase (95% CI, 24.5-31.2 percentage points) in the receipt of antidiabetic agents in the adjusted model. The policy was also associated with a 10.4-percentage-point (95% CI, 5.3-15.5 percentage points) increase in insulin use during pregnancy among all patients with gestational diabetes. We observed an increase in postpartum contraceptive use (21.2 percentage points; 95% CI, 14.9-27.5 percentage points), the majority of which was due to postpartum sterilization (increase of 16.1 percentage points; 95% CI, 10.4-21.8 percentage points). We did not observe a significant association with gestational hypertension, cesarean births, or newborn health.
CONCLUSIONS AND RELEVANCE: This retrospective cohort study suggests that expanded emergency Medicaid benefits that included prenatal care were associated with an increased use of antidiabetic medications and postpartum contraception during pregnancy.
参考来源
- Rodriguez MI, Martinez Acevedo A, Swartz JJ, et al. Association of Prenatal Care Expansion With Use of Antidiabetic Agents During Pregnancies Among Latina Emergency Medicaid Recipients With Gestational Diabetes. JAMA Netw Open. 2022. PMID: 35486400. doi:10.1001/jamanetworkopen.2022.9562
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。